News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
About the Author - Alex Keown

BioSpace News - By Alex Keown
MIT Launches Ambitious Accelerator to Help Fund and Guide 'Tough' Startups 10/27/2016
Bristol-Myers Squibb (BMY) to Revamp R&D and Streamline Operations After Opdivo Failure 10/27/2016
Allergan (AGN) Takes Out GI Firm Motus in $200 Million Deal 10/27/2016
FDA Slaps Clinical Hold on AstraZeneca PLC (AZN)'s Phase III Head and Neck Cancer Program 10/27/2016
23andMe Kills Its Next Generation Gene Sequencing Project, Cuts Jobs 10/27/2016
This is Why Novartis AG (NVS) Folded Its CAR-T Unit 10/26/2016
This Little Biotech in North Carolina Could be the Next Antibiotic Buyout 10/26/2016
The Only Way Troubled MannKind (MNKD) Might be Able to Avoid Bankruptcy 10/26/2016
Watch Out Juno (JUNO) and Kite Pharma (KITE): Novartis AG (NVS) Clearly Not Done With CAR-T 10/26/2016
GlaxoSmithKline (GSK) Terminates Development of Losmapimod for COPD 10/26/2016
Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus (CRBP) is About to Crash 10/25/2016
Tiny Dipexium (DPRX) Craters After Lead Drug Locilex Flunks Phase III Trials 10/25/2016
How Florida Landed Johnson & Johnson (JNJ) and the Promise of 500 New Jobs 10/25/2016
Catalent (CTLT)'s $34 Million Expansion to Create 100 New Jobs in Wisconsin 10/25/2016
Alkermes (ALKS) Rockets as Depression Drug Aces Key Late-Stage Trial 10/24/2016
Amgen (AMGN)'s Partner Unilife  (UNIS) Slashes 140 Jobs and Will Sublet Portion of Pennsylvania Office Space 10/24/2016
Why This 27-Employee Biotech is Outperforming Every Public Massachusetts Company This Year 10/24/2016
Bernie Sanders Demands Info on Ariad (ARIA)'s Leukemia Drug 10/24/2016
Roche (RHHBY)'s Avastin Successor Flunks Key Study, Turns Hope to Tecentriq Instead 10/21/2016
Alkermes (ALKS)' Success Puts the Spotlight on Cerecor, Eli Lilly (LLY)'s 2015 Deal 10/21/2016
Top 5 Best U.S. Cities for Pharma and Biotech Scientist Jobs 10/20/2016
CRISPR (CRSP) IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year 10/20/2016
Health Care Giant AmerisourceBergen (ABC) Moving Thousands Of Employees to New Carrollton Campus 10/20/2016
Rigel (RIGL)'s Bleeding Disorder Drug Flunks Phase III Test, Stock Tanks 10/20/2016
Biotech Goes Hollywood Again as Jennifer Lopez Set to Produce New Show About CRISPR Gene-Editing 10/20/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T? 10/20/2016
Pharmascience Cuts Approximately 90 Jobs at Head Office 10/19/2016
19 Bay Area Biotechs to Watch at BIO's Investor Forum This Week 10/19/2016
With Ties to the Bay Area, ADC Therapeutics Pulls in $105 Million 10/19/2016
How One Tweet From Bernie Sanders Sent Ariad (ARIA)'s Stock Plunging 10/19/2016
Despite Bashing the Pharma Industry, More Than Half of Biotech Execs Surveyed Still Support Hillary Clinton 10/19/2016
After Hep C Flop, Has Vertex (VRTX) Learned From Its Past Mistakes? 10/18/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab 10/18/2016
A Look at CRISPR, 'Biotech's Biggest Discovery of the Century,' and the 3 Companies Knee Deep in It 10/17/2016
All Eyes on Eli Lilly (LLY)'s Large-Scale Alzheimer's Trial 10/17/2016
Meet Amber Salzman, the Female CEO to Helm Bay Area's Adverum Biotechnologies 10/17/2016
Watch Out, Ionis Pharma (IONS): Could This Little Biotech’s Experimental SMA Treatment Be a Threat? 10/17/2016
The History Between a Biogen (BIIB) Drug and a High-Profile Democratic Party Fundraiser 10/17/2016
PTC Therapeutics (PTCT) Tanks After the FDA Denies DMD Drug Translarna Again 10/17/2016
Former Novartis AG (NVS) CAR-T Scientist Jumps to TxCell to Lead CAR-Treg Research Programs 10/17/2016
Pfizer (PFE) Retracts 5 Articles Authored by Top Cancer Researcher Who Has Since Left the Company 10/14/2016
3 Biotechs With Cancer Drugs That Could Win Approval in 2017 10/14/2016
Tesaro (TSRO) Attempts to Squash Partner Myriad Genetics (MYGN)’ Contrary Press Release Over Niraparib 10/14/2016
Regeneron (REGN) Bets $315 Million on Ocular Therapeutix (OCUL) for an Upgraded Form of Eylea 10/14/2016
Drug Pricing Woes Hit Vertex (VRTX) as One Mom Travels to Boston to Take on CEO 10/14/2016
Check Out These 20 Boston Area Biotechs That Spent Less on R&D This Year 10/14/2016
Google (GOOG)'s Verily to Not Only Tackle Diabetes, But Zika as Well 10/14/2016
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial 10/12/2016
Allergan (AGN) Looks to Expand Beyond Botox with Oral Migraine Treatments 10/12/2016
Major Investor Sues Theranos Over 'Series of Lies' in $100 Million Suit 10/12/2016
Anger Behind the Scenes When Valeant (VRX) Jacked Up Price by 2,700% for Lead Poisoning Drug 10/12/2016
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee 10/11/2016
Tesaro (TSRO) Jumped on PARP Ovarian Cancer Win Vs. AstraZeneca PLC (AZN), AbbVie (ABBV) 10/11/2016
Why Amgen (AMGN), Biogen (BIIB) and Celgene (CELG) are the Best Biotech Stocks Now 10/11/2016
A Look at This Tiny Massachusetts Biotech That Could Take Down Alzheimer's 10/11/2016
Cell Phones and Documents are Seized From Some Hanmi Pharma (128940.KS) Employees on Suspicion of Insider Information Leak 10/11/2016
Embattled Theranos to Shut Down All Labs and Testing Centers, Cuts About 40% of Workforce 10/10/2016
Bristol-Myers Squibb (BMY) Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co. (MRK)'s Keytruda Shines in Lung Cancer Study 10/10/2016
Retrophin (RTRX)'s R&D Head Resigns to Helm Unnamed Biotech Startup 10/7/2016
Deal Spree Continues as AstraZeneca PLC (AZN) Inks $330 Million Pact With Johnson & Johnson (JNJ) 10/7/2016
How Struggling Ariad (ARIA) Used a Safety Problem to Quietly Raise Cancer Drug Price 10/7/2016
UK's NuPharm Laboratories to Close With Loss of 66 Jobs 10/7/2016
CRO Biotrial, The Company That Ran Fateful Drug Trial in France, Opens Test Facility in New Jersey 10/6/2016
Metabrain Research, Medicxi Launch UK Firm Kymo Therapeutics 10/6/2016
Merck & Co. (MRK) to Slash Another 112 Jobs in Florida 10/6/2016
Syncona, Cancer Research Technology Launch Achilles With $17.5 Million 10/6/2016
UK's Orchard Therapeutics to Open Up Shop in the Bay Area 10/6/2016
Novartis AG (NVS) Shakes it Up Again, Moving Singapore Facility to the Bay Area and Will Create New R&D Ops in Massachusetts and Basel 10/6/2016
Pfizer (PFE) Rumored to Begin Slashing Hundreds of Employees at North Carolina Facility 10/5/2016
On a Roll, AstraZeneca PLC (AZN) Licenses Respiratory Drug to Insmed (INSM) in $150 Million Deal 10/5/2016
AstraZeneca PLC (AZN) Furthers Sell-Off Strategy With New $175 Million Deal 10/4/2016
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial 10/4/2016
Celldex (CLDX) Who? 2 Not-as-Risky Stocks That Shot Up in the Past Year 10/4/2016
Merrimack (MACK) CEO Steps Down as Company Slashes 22% of Jobs 10/4/2016
Massachusetts VC-Backed Biotech Ra Pharma Files for $86 Million IPO 10/3/2016
Former Inyx CEO Charged in $100 Million Fraud Scheme 10/3/2016
Regeneron (REGN), Sanofi (SNY) Tout Phase III Dupixent Data 10/3/2016
Trial Failure Forces Bay Area's Threshold Pharma (THLD) to Cut Almost a Quarter of Workforce 10/3/2016
Swiss Biotech Giant Lonza Inc. to Open New Facility in Houston Suburb, Will Hire 100 Initially But Hundreds of Jobs to Come 9/30/2016
Former INSYS Sales Manager is Arrested in Opioid Kickback Scheme 9/30/2016
Denmark's LEO Pharma Opens Up Shop in Cambridge 9/30/2016
SoCal's Arrowhead Pharma (ARWR) Just Snagged a $673.5 Million Heart Deal With Amgen (AMGN) 9/30/2016
MediGene AG (MDGEF.PK), bluebird bio (BLUE) Partner Up in $1 Billion+ Cancer Immunotherapy Deal 9/29/2016
4 Biotech Stars That Will Beat the Stock Slump 9/29/2016
Boston-based Ginkgo BioWorks Opens World’s Largest Biotech Foundry to Increase Production Capacity 9/29/2016
After Emma Walmsley's Promotion, GlaxoSmithKline (GSK) Taps Former Novartis AG (NVS) Exec to Head Consumer Unit 9/29/2016
It's a Beautiful Day as U2's Bono, Others Back Bay Area Color Genomics's $45 Million Funding Round 9/29/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure 9/28/2016
Kite Pharma (KITE) Claims Success for Phase II CAR-T Study, Stock Soars 9/28/2016
How Alkermes (ALKS) Transformed an Anti-Addiction Drug From a Bust to a Hit 9/28/2016
Drug Giant Bristol-Myers Squibb (BMY) Ties it Up With Another Bay Area Firm in Cancer Immunotherapy Quest 9/28/2016
GlaxoSmithKline (GSK) Finally Finds a Buyer for Its Paris R&D Site, 57 Staffers Affected 9/28/2016
6 Biotechs Revving Up for a Massive 50% to 150% Upside 9/28/2016
The Scientific Advisors at Theranos Won't (or Can't) Talk 9/27/2016
Neon Therapeutics Taps Former Novartis AG (NVS) Cancer Vet as New CEO 9/27/2016
Imprimis (immy) Axes 8% of Staff, Shuts Down Texas Facility 9/27/2016
North Carolina's Biologics to Pink Slip Another 132 Workers 9/26/2016
Shkreli Called it: Mast Therapeutics (MSTX) Begins Winding Down Vepoloxamer Programs 9/26/2016
FDA Clears Amgen (AMGN) Copy of AbbVie (ABBV)'s Blockbuster Humira 9/26/2016
Drumroll, Please...GlaxoSmithKline (GSK) Just Named This Woman Its New CEO 9/23/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again 9/23/2016
35 U.S. States Sue British Drugmaker Indivior Over Marketing of Opioid 9/23/2016
What's Going On With The Biotech Job Market? 9/23/2016
Valeant (VRX) Slaps 'For Sale' Sign on iNova Pharma, Deal Could Bring in $1 Billion+ 9/23/2016
Clovis Oncology (CLVS) (Once Again) Becomes a Takeover Topic, But Some Wonder Whether It's All Hype 9/23/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug 9/23/2016
Ireland Makes Its Case to Be New Home for the EMA Following Brexit 9/23/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic 9/22/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected 9/22/2016
Calico Responds to Job Cut Rumors 9/22/2016
Avadim Tech to Create 551 Jobs at New N.C. HQ 9/22/2016
Allergan (AGN)'s NASH Spree Continues With $50 Million+ Buyout of San Diego's Akarna Therapeutics 9/21/2016
Struggling Eleven Bio (EBIO) Scoops Up Canadian Biotech, CEO Steps Down 9/21/2016
Vertex (VRTX) TV Show Seeks Help From Boston Heavyweights Like Matt Damon or Mark Wahlberg 9/21/2016
Bay Area-based Bulletproof Documentation Looks to Make a Name in the Life Science Technical Writing Market 9/21/2016
Pfizer (PFE) to Shut Down New York Plant, 120 Staffers Affected 9/21/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab 9/20/2016
Bayer (BAY) Considers Dropping Monsanto (MON) Name to Avoid 'Sullying Its Reputation' 9/20/2016
Another Good Day for Amgen (AMGN) as Repatha Phase III GLAGOV Trial Met Primary, Secondary Endpoints 9/20/2016
Why Rigel (RIGL)'s Layoffs May Not be a Bad Thing 9/19/2016
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Showed Significant Results in Phase III Study 9/19/2016
Spectrum Pharma (SPPI) Allegedly Hid a Key Detail From a Meeting With the FDA 9/19/2016
Bayer (BAY), Monsanto (MON)'s $66 Billion Marriage Could Cost 6,666 U.S. Jobs 9/19/2016
Novavax (NVAX) Stayin' Alive After Shares Crater on Flunked Phase III 9/19/2016
Could Biotech's Bestie Celgene (CELG) Be Getting Ready to Unveil Another Deal? 9/19/2016
Boston 'Unicorn' Intarcia Banks a Whopping $215 Million to Support Diabetes Drug Pump 9/19/2016
Hungry Like a Wolf, Takeda (TKPYY) Sets Aside $15 Billion Cash for U.S. Acquisitions 9/16/2016
Flooding Halts Work at GlaxoSmithKline (GSK) Plant 9/16/2016
Could There be a Marriage Between Valeant (VRX) and Allergan (AGN)? 9/15/2016
Boston's Ginkgo BioWorks Brews Up Jobs and Beer 9/15/2016
The Lone Star State's Peloton Therapeutics Rakes in $52.4 Million 9/15/2016
Bayer (BAY), Monsanto (MON) Give No Clues on How the $66 Billion Merge Will Impact RTP Jobs 9/15/2016
Spending Spree Continues as Allergan (AGN) Pays $639 Million for Vitae Pharma (VTAE) 9/15/2016
People of Indiana Disappointed as World's Richest Doctor's NantWorks Will Not Expand at Old Pfizer (PFE) Property 9/14/2016
Good or Bad? Pharma Bro Thinks Jazz Pharma (JAZZ) Could be Worth $20 Billion, Calls Mast Therapeutics (MSTX) 'Worthless' 9/14/2016
How Arizona Republicans Also Fell Head-Over-Heels for Theranos's Elizabeth Holmes 9/14/2016
2 Bargain Pharma Stocks to Snag No Matter Who is Elected 9/14/2016
Another One Bites the Dust... Horizon Pharma (HZNP) Takes Out Bay Area's Raptor (RPTP) in $800 Million Deal 9/14/2016
How Sweet It is as Bayer (BAY) Finally Clinches Monsanto (MON) With $66 Billion Deal 9/14/2016
BOO! Big Pharmas Like GlaxoSmithKline (GSK), Pfizer (PFE) and Mylan (MYL) Use Scare Tactics to Drum Up Sales 9/13/2016
Struggling AVEO Oncology (AVEO) Quietly Discontinues Phase II Ficlatuzumab Study 9/13/2016
Pharma Bro Martin Shkreli Heckles Hillary Clinton: 'Are You Alive?' 9/12/2016
Let's Not Stay Together...Takeda (TKPYY) and MacroGenics (MGNX) Nix Agreement 9/12/2016
Lexicon Pharma (LXRX) Rockets on Late-Stage Diabetes Drug Data 9/12/2016
Clovis Oncology (CLVS) Stock Jumps as FDA Skips Review Panel for New Cancer Drug 9/12/2016
Juno (JUNO) Surges as Small Cancer Study is Hailed a Success, Shows Promise for Other Drugs 9/9/2016
New Details of Theranos Implosion Makes Great Fodder for Jennifer Lawrence Movie 9/9/2016
5 Myths About Mylan (MYL)'s EpiPen Scandal 9/9/2016
Advice for Biogen (BIIB): Take a Page Out of Biotech's Best Friend Celgene (CELG)'s Playbook 9/9/2016
Deflated Tokai Pharma (TKAI) to Review Strategic Alternatives, Including Possible Sale 9/8/2016
San Diego's Fate Therapeutics (FATE) Lands a Deal With Star Scientist to Work on Off-the-Shelf T-Cell Immunotherapies 9/8/2016
5 Biotechs Under $10 With Massive Potential 9/8/2016
Juno (JUNO), Kite Pharma (KITE) Fall After Novartis AG (NVS) Dissolves CAR-T Unit 9/6/2016
Novartis AG (NVS) Purges Senior Execs as It Carts Itself Off 9/6/2016
Mylan (MYL) Rebuffs Rumors CEO Will Step Down 9/6/2016
Danaher (DHR) Coughs Up About $4 Billion for Diagnostics Maker Cepheid (CPHD) 9/6/2016
Novartis AG (NVS) to Dissolve Cell and Gene Therapy Unit, Move Affects 400 Staffers 9/2/2016
PAREXEL (PRXL) Loses $160 Million in Value in One Day After Disclosing Possible 'Misappropriation of Corporate Funds' 9/2/2016
GlaxoSmithKline (GSK) Opens Up 'Smart Space' to Test New Technology 9/2/2016
Cidara (CDTX) CMO Jumps Ship to Helm Unnamed Bay Area Biotech 9/2/2016
Roche (RHHBY) to Streamline Operations in Switzerland, 190 Workers Affected 9/2/2016
GenVec (GNVC) Will Not be Affected by Novartis AG (NVS)' Dissolution of CAR-T Unit 9/1/2016
Massachusetts' Sunovion Swallows Up Cynapsus (CYNA) in $624 Million Deal, Gains Experimental Parkinson's Drug 9/1/2016
More Trouble for Theranos as FDA Discovers Company Cut Corners With Zika Test 9/1/2016
Onconova (ONTX) Quietly Terminates Another 21% of Its Workforce 8/31/2016
Crown Bioscience Names a New CEO and CFO 8/31/2016
Bay Area Startup Arcus Biosciences Emerges With $120 Million 8/30/2016
2 Biotech Stocks Billionaire Investor George Soros Dumped. Should You? 8/30/2016
Mylan (MYL) CEO in 2006 Slammed Practice It’s Now Using on EpiPen 8/30/2016
With 11 Drugs in the Pipeline Already, Cash-Rich Moderna Eyes Another $600 Million 8/30/2016
Atlanta's Immucor to Expand in Milwaukee, Will Hire 64 New Employees 8/30/2016
AbSci Inks Lease for New HQ in Washington, Plans to Hire 8/30/2016
23andMe Ancestry Tests Allegedly Have Issues With People of Color 8/30/2016
Massachusetts Cancer Diagnostics Company Mitra Biotech Scores $27.4 Million 8/29/2016
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen 8/26/2016
Job Cuts Loom as Takeda (TKPYY) to Shutter Cambridge Office and Quits the UK 8/26/2016
Embattled Theranos Plans to Appeal to Re-Open Its Lab in Newark, California 8/26/2016
Best Places to Work in Life Sciences for LGBT Equality 8/25/2016
Teva (TEVA) Stock Plummets After Two Patents are Invalidated by Mylan (MYL) 8/25/2016
Mylan (MYL) CEO Gets a 600% Pay Raise During Epipen's 400% Price Hike, Is She the Next Martin Shkreli? 8/25/2016
McKesson (MCK) Slaps 'For Sale' Sign on San Francisco HQ With Plans to Lease Back a Portion of Building 8/25/2016
Months After Infamous 'Sexist' Biotech Party, 20 Women Join New Exec Training 8/25/2016
Turing CCO Claims Execs Retaliated After Shkreli’s Friend and Co-Founder Resigned Due to Sexual Assault Allegations 8/25/2016
MIT Scientist Leonard Guarente Claims That This Pill Is the Fountain of Youth 8/25/2016
Valeant (VRX) Offers Details on Incoming CFO's Compensation; Will Get $10 Million in 'Make-Up Cash' 8/24/2016
Outrage Ensues After Mylan (MYL) Raises EpiPen Price by 400% 8/24/2016
Pfizer (PFE) to Shut Down Four Hospira Distribution Centers 8/24/2016
Merrion Pharma Looks to Wind Up Operations, Announces Liquidation Plans 8/23/2016
Advaxis (ADXS)' Resurrection and the Man Behind It All 8/23/2016
Google (GOOG)'s Verily HQ in the Peninsula Needs More Time, Company Seeks Timeline Extension 8/23/2016
Rumors Again Swirl Over BioMarin (BMRN) Being a Possible Plan B for Sanofi (SNY) 8/23/2016
DS Biopharma Spins Out New Company Focused on Fibrotic Conditions and Pulmonary Disorders 8/22/2016
Booming Arbutus Biopharma (ABUS) Relocating HQ to Warminster for More Space 8/22/2016
Nephron Pharma Chops Another 60 Jobs as it Transitions Out of Florida and Into New South Carolina HQ 8/22/2016
Korean Firms Acquire Novo Nordisk A/S (NVO)’s U.S. HQ for $305 Million 8/19/2016
2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now 8/19/2016
Trial Failure Prompts Cerulean (CERU) to Pink Slip 48% of Workforce 8/19/2016
Mallinckrodt (MNK) to Build New $80 Million+ Campus in New Jersey With Space for 400 Employees 8/19/2016
Juno (JUNO) Facing Class Action Lawsuit Following Patient Deaths 8/19/2016
19 Deaths Force Medtronic (MDT) to Warn Doctors on Heart Valve Delivery System 8/18/2016